Previous 10 | Next 10 |
Gainers: Virax Biolabs ( VRAX ) +62% . Aethlon Medical ( AEMD ) +46% . GeoVax Labs ( GOVX ) +46% . Celyad Oncology ( CYAD ) +40% . Outset Medical ( OM ) +28% . Losers: Otonomy ( OTIC ) -77% . Kazia Therapeu...
Otonomy ( OTIC ) -68% reports results from Phase 2 clinical trial of OTO-313 in patients with Tinnitus. Kazia Therapeutics ( KZIA ) -47% . Senti Biosciences ( SNTI ) -18% . FaZe Holdings ( FAZE ) -17% . Beam Therapeutics ( BEAM )...
KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER PR Newswire SYDNEY , July 12, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is please...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Photographee.eu / Shutterstock.com Kazia Therapeutics (NASDAQ: KZIA ) stock is taking off on Wednesday following an update from the U.S. Food and Drug Administration (FDA) for its pediatric cancer treat...
US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER PR Newswire SYDNEY , July 6, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug developme...
The ADRs of Australian biotech Kazia Therapeutics ( NASDAQ: KZIA ) gained 8% Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) granted the Rare Pediatric Disease Designation for an experimental therapy targeted at a form of childhood ca...
Fujian Blue Hat Interactive Entertainment Technology (BHAT) -45%. ACADIA Pharmaceuticals (ACAD) -33% as trading resumes after FDA snub for antipsychotic drug. Addex Therapeutics (ADXN) -11%. Kazia Therapeutics (KZIA) -7%. Gran Tierra Energy (GTE) -6%. PolarityTE (PTE) -6% ...
Kazia Therapeutics (NASDAQ:KZIA) on Friday said that the U.S. FDA had granted an orphan drug designation to its inhibitor paxalisib for the treatment of atypical rhabdoid / teratoid tumors (AT/RT), a rare and highly-aggressive childhood brain cancer. U.S.-listed shares of KZIA ...
Revlon REV +78% spikes as Indian conglomerate reportedly eyes buyout. Blackboxstocks (BLBX) +21%. Kazia Therapeutics (KZIA) +14% as US FDA awards orphan drug designation to Paxalisib for AT/RT. Alibaba Group Holding BABA +10% on report China PBOC accepts Ant applicati...
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER PR Newswire SYDNEY , June 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company,...
News, Short Squeeze, Breakout and More Instantly...
Kazia Therapeutics Limited Company Name:
KZIA Stock Symbol:
NASDAQ Market:
Kazia Therapeutics Limited Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 0.6% to $128.44 on volume of 203,267,889 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 22.1% to $0.5152 on volume of 200,531,827 shares PROSHARES TRUST (SQQQ) fell 0.7% to $7.46 on volume o...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...